Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary ...

Reports

3

Domains carrying it

3

First reported

24 August 2026

Latest report

28 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 24 August 2026Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary ...biospace.com
2. 28 August 2026Tempus AI (TEM) Is Up 6.1% After New FDA-Cleared ECG PH Toolsimplywall.st

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• Medibyt Receives FDA 510(k) Clearance for CPETWise, Advancing Cardiopulmonary ...5 reports · 5 domains · 4 September 2026
• FDA Clears AI-Powered Breast Ultrasound Software from DeepHealth3 reports · 3 domains · 4 August 2026
• J&J's Monarch robot wins FDA nod for AI features4 reports · 4 domains · 18 August 2026
• Co-Diagnostics submits FDA 510(k) for respiratory test2 reports · 2 domains · 7 August 2026
• Most FDA-cleared AI medical devices not tested on patient outcomes3 reports · 3 domains · 24 August 2026
• FDA Floats Competency-Based Regs For Generative AI-Enabled Devices15 reports · 12 domains · 2 September 2026

◆ Share

◆ Evidence

3 reports · 3 domains

• Tempus AI (TEM) Is Up 6.1% After New FDA-Cleared ECG PH Toolsimplywall.st · 28 August 2026
• FDA clears AI software for detecting untreated pulmonary hypertension in 12-lead ECGscardiovascularbusiness.com · 24 August 2026
• Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary ...biospace.com · 24 August 2026